Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Type I interferons play a key role in the development of various skin diseases.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Tofacitinib is effective and safe for treating severe alopecia areata.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Upadacitinib may effectively treat alopecia areata without side effects.

HIV can cause unusual and severe skin problems that are hard to treat.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

A gene deletion in mice causes weak protein, immune issues, hair loss, airway problems, and wasting disease.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Mitochondrial genes help predict breast cancer outcomes and spread.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.